/Morrison_Foerster.gif)
/Clinical_trial_470_x_80_(new).gif)
Positive Genzyme studies results
8 August - The Genzyme drug candidate Mozobil has shown postive results in two separate Phase III clinical studies. Read more
Active Biotech has received FDA approval to test TASQ
10 August - The review of Active Biotech's IND (Investigational New Drug) for the TASQ prostate cancer project has been completed by the US Food and Drug Administration (FDA). A Phase II proof of concept trial in prostate cancer patients will now be initiated. Read more
Phase II trial results for ADENTRI published in scientific journal
14 August - Biogen Idec has announced that positive results of a Phase II study of oral ADENTRI®, an A1 adenosine receptor antagonist, in stable heart failure patients have been published in today's issue of the Journal of the American College of Cardiology. Read more
Positive phase III trials result with Liraglutide
20 August - Novo Nordisk has announced clinical results from the second and third of five phase 3 studies with liraglutide. The two studies are part of the LEAD® programme and they investigated the effect of different doses of liraglutide in combination with a single oral. Read more
/Anne_Katrine.gif)
|
Anne Katrine Nørgaard E: akn@mva.org T: +45 3532 4155 M: +45 2875 4155 |